Last reviewed · How we verify

NCT05299294: CAPSULE

Observational Study of the Use of 8% Capsaicin Patch in Children 0 to 18 Years Old

Recruiting now Last updated 24 September 2024
What this trial tests

trial testing Data collection in Neuropathic Pain in 160 participants. Currently enrolling.

Timeline
12 May 2022
Primary endpoint
12 May 2027
12 September 2027

Quick facts

Lead sponsorUniversity Hospital, Brest
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment160
Start date12 May 2022
Primary completion12 May 2027
Estimated completion12 September 2027
Sites20 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Brest

Who can join

Under 17, any sex, with Neuropathic Pain or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients aged less than 18-y with validated 8% capsaicin patch treatment in routine healthcare will be offered to participate the study. If they accept it as well as their parents, they will be included in the study . Medical data will be recorded and at home, the child or his family will collect pain assessment data. Tolerance will be monitored at home by phone call from investigational team every 24 hours until normalization. (Less than 24 hours for 75%, 100% to 72 hours on unpublished personal series.) Children will be assessed via scales at inclusion and 1-month, 3-month and 6-month.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Data collection

Trials testing the same drug.

Other recruiting trials for Neuropathic Pain

Currently open trials in the same condition.

Other University Hospital, Brest trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05299294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing